<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34912345</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities.</ArticleTitle><Pagination><StartPage>778913</StartPage><MedlinePgn>778913</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">778913</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.778913</ELocationID><Abstract><AbstractText>The current global pandemic of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) causing COVID-19, has infected millions of people and continues to pose a threat to many more. Angiotensin-Converting Enzyme 2 (ACE2) is an important player of the Renin-Angiotensin System (RAS) expressed on the surface of the lung, heart, kidney, neurons, and endothelial cells, which mediates SARS-CoV-2 entry into the host cells. The cytokine storms of COVID-19 arise from the large recruitment of immune cells because of the dis-synchronized hyperactive immune system, lead to many abnormalities including hyper-inflammation, endotheliopathy, and hypercoagulability that produce multi-organ dysfunction and increased the risk of arterial and venous thrombosis resulting in more severe illness and mortality. We discuss the aberrated interconnectedness and forthcoming crosstalks between immunity, the endothelium, and coagulation, as well as how sex disparities affect the severity and outcome of COVID-19 and harm men especially. Further, our conceptual framework may help to explain why persistent symptoms, such as reduced physical fitness and fatigue during long COVID, may be rooted in the clotting system.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Emadi-Baygi, Ehsanifard, Afrashtehpour, Norouzi and Joz-Abbasalian.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emadi-Baygi</LastName><ForeName>Modjtaba</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehsanifard</LastName><ForeName>Mahsa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afrashtehpour</LastName><ForeName>Najmeh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norouzi</LastName><ForeName>Mahnaz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Research and Development, Erythrogen Medical Genetics Lab, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joz-Abbasalian</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinical Laboratory, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="N">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004727" MajorTopicYN="N">Endothelium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="N">Renin-Angiotensin System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">coagulation</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">interconnectedness</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword></KeywordList><CoiStatement>MN was employed by Erythrogen Medical Genetics Lab. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34912345</ArticleId><ArticleId IdType="pmc">PMC8667725</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.778913</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, MacAry PA, Ng LFP. The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nat Rev Immunol (2020) 20(6):363&#x2013;74. doi: 10.1038/s41577-020-0311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G, et al. . Evolution Patterns of SARS-CoV-2: Snapshot on Its Genome Variants. Biochem Biophys Res Commun (2021) 538:88&#x2013;91. doi: 10.1016/j.bbrc.2020.10.102</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.10.102</ArticleId><ArticleId IdType="pmc">PMC7836704</ArticleId><ArticleId IdType="pubmed">33199021</ArticleId></ArticleIdList></Reference><Reference><Citation>Haney S, Bardwell L, Nie Q. Ultrasensitive Responses and Specificity in Cell Signaling. BMC Syst Biol (2010) 4:119. doi: 10.1186/1752-0509-4-119</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-4-119</ArticleId><ArticleId IdType="pmc">PMC2940771</ArticleId><ArticleId IdType="pubmed">20735856</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland MA, Greenbaum JM, Deeds EJ. Crosstalk and the Evolvability of Intracellular Communication. Nat Commun (2017) 8(1):1&#x2013;8. doi: 10.1038/ncomms16009</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms16009</ArticleId><ArticleId IdType="pmc">PMC5508131</ArticleId><ArticleId IdType="pubmed">28691706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Lu L, Cao W, Li T. Hypothesis for Potential Pathogenesis of SARS-CoV-2 Infection&#x2013;A Review of Immune Changes in Patients With Viral Pneumonia. Emerg Microbes Infect (2020) 9(1):727&#x2013;32. doi: 10.1080/22221751.2020.1746199</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1746199</ArticleId><ArticleId IdType="pmc">PMC7170333</ArticleId><ArticleId IdType="pubmed">32196410</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell (2020) 181(2):271&#x2013;80.e8. doi: 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. . A Pneumonia Outbreak Associated With a New Coronavirus of Probable Bat Origin. Nature (2020) 579(7798):270&#x2013;3. doi: 10.1038/s41586-020-2012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells (2020) 9(7):1652. doi: 10.3390/cells9071652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9071652</ArticleId><ArticleId IdType="pmc">PMC7407648</ArticleId><ArticleId IdType="pubmed">32660065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulandari L, Hamidah B, Pakpahan C, Damayanti NS, Kurniati ND, Adiatmaja CO, et al. . Initial Study on TMPRSS2 P.Val160Met Genetic Variant in COVID-19 Patients. Hum Genomics (2021) 15(1):1&#x2013;9. doi:&#xa0;10.1186/s40246-021-00330-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-021-00330-7</ArticleId><ArticleId IdType="pmc">PMC8127183</ArticleId><ArticleId IdType="pubmed">34001248</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanachandra Singh K, Karnik SS. Angiotensin Receptors: Structure, Function, Signaling and Clinical Applications. J Cell Signal (2017) 01(02):1&#x2013;2. doi: 10.4172/2576-1471.1000111</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2576-1471.1000111</ArticleId><ArticleId IdType="pmc">PMC4976824</ArticleId><ArticleId IdType="pubmed">27512731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. . Role of Angiotensin-Converting Enzyme 2 (ACE2) in COVID-19. Crit Care (2020) 24(1):1&#x2013;10. doi:&#xa0;10.1186/s13054-020-03120-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Moore MJ, Vasllieva N, Sui J, Wong SK, Berne MA, et al. . Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the SARS Coronavirus. Nature (2003) 426(6965):450&#x2013;4. doi: 10.1038/nature02145</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla AK, Banerjee M. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update. High Blood Press Cardiovasc Prev (2021) 28(2):129&#x2013;39. doi: 10.1007/s40292-021-00439-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-021-00439-9</ArticleId><ArticleId IdType="pmc">PMC7908946</ArticleId><ArticleId IdType="pubmed">33635533</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese OJ, Allwood BW, Zemlin AE. COVID-19 and the Renin-Angiotensin System (RAS): A Spark That Sets the Forest Alight? Med Hypotheses (2020) 144:110231. doi: 10.1016/j.mehy.2020.110231</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110231</ArticleId><ArticleId IdType="pmc">PMC7468676</ArticleId><ArticleId IdType="pubmed">33254538</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China. Lancet (2020) 395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA - J Am Med Assoc (2020) 323(13):1239&#x2013;42. doi: 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Morales AJ, Cardona-Ospina JA, Guti&#xe9;rrez-Ocampo E, Villamizar-Pe&#xf1;a R, Holguin-Rivera Y, Escalera-Antezana JP, et al. . Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-Analysis. Travel Med Infect Dis (2020) 34:101623. doi: 10.1016/j.tmaid.2020.101623</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2020.101623</ArticleId><ArticleId IdType="pmc">PMC7102608</ArticleId><ArticleId IdType="pubmed">32179124</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Cao Q, Qin L, Wang X, Cheng Z, Pan A, et al. . Clinical Characteristics and Imaging Manifestations of the 2019 Novel Coronavirus Disease (COVID-19):A Multi-Center Study in Wenzhou City, Zhejiang, China. J&#xa0;Infect (2020) 80(4):388&#x2013;93. doi: 10.1016/j.jinf.2020.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.02.016</ArticleId><ArticleId IdType="pmc">PMC7102539</ArticleId><ArticleId IdType="pubmed">32112884</ArticleId></ArticleIdList></Reference><Reference><Citation>Im Kampe EO, Lehfeld AS, Buda S, Buchholz U, Haas W. Surveillance of COVID-19 School Outbreaks, Germany, March to August 2020. Eurosurveillance (2020) 25(38):2001645. doi:&#xa0;10.2807/1560-7917.ES.2020.25.38.2001645</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.38.2001645</ArticleId><ArticleId IdType="pmc">PMC7533620</ArticleId><ArticleId IdType="pubmed">32975186</ArticleId></ArticleIdList></Reference><Reference><Citation>Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clin Appl Thromb (2020) 26:1&#x2013;7. doi: 10.1177/1076029620938149</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620938149</ArticleId><ArticleId IdType="pmc">PMC7370334</ArticleId><ArticleId IdType="pubmed">32677459</ArticleId></ArticleIdList></Reference><Reference><Citation>Farshbafnadi M, Kamali Zonouzi S, Sabahi M, Dolatshahi M, Aarabi MH. Aging &amp; COVID-19 Susceptibility, Disease Severity, and Clinical Outcomes: The Role of Entangled Risk Factors. Exp Gerontol (2021) 154:111507. doi: 10.1016/j.exger.2021.111507</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2021.111507</ArticleId><ArticleId IdType="pmc">PMC8329427</ArticleId><ArticleId IdType="pubmed">34352287</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindler E, Thiel V, Weber F. Interaction of SARS and MERS Coronaviruses With the Antiviral Interferon Response. Adv Virus Res (2016) 96:219&#x2013;43. doi: 10.1016/bs.aivir.2016.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.aivir.2016.08.006</ArticleId><ArticleId IdType="pmc">PMC7112302</ArticleId><ArticleId IdType="pubmed">27712625</ArticleId></ArticleIdList></Reference><Reference><Citation>Prompetchara E, Ketloy C, Palaga T. Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned From SARS and MERS Epidemic. Asian Pac J Allergy Immunol (2020) 38(1):1&#x2013;9. doi: 10.12932/AP-200220-0772</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP-200220-0772</ArticleId><ArticleId IdType="pubmed">32105090</ArticleId></ArticleIdList></Reference><Reference><Citation>Larenas-Linnemann D, Rodr&#xed;guez-P&#xe9;rez N, Arias-Cruz A, Bland&#xf3;n-Vijil MV, Del R&#xed;o-Navarro BE, Estrada-Cardona A, et al. . Enhancing Innate Immunity Against Virus in Times of COVID-19: Trying to Untangle Facts From Fictions. World Allergy Organ J (2020) 13(11):100476. doi: 10.1016/j.waojou.2020.100476</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2020.100476</ArticleId><ArticleId IdType="pmc">PMC7546230</ArticleId><ArticleId IdType="pubmed">33072240</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Pathogenic Human Coronavirus Infections: Causes and Consequences of Cytokine Storm and Immunopathology. Semin Immunopathol (2017) 39(5):529&#x2013;39. doi: 10.1007/s00281-017-0629-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0629-x</ArticleId><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Alipoor SD, Mortaz E, Jamaati H, Tabarsi P, Bayram H, Varahram M, et al. . COVID-19: Molecular and Cellular Response. Front Cell Infect Microbiol (2021) 11:563085. doi: 10.3389/fcimb.2021.563085</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.563085</ArticleId><ArticleId IdType="pmc">PMC7904902</ArticleId><ArticleId IdType="pubmed">33643932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, et al. . Coagulation Dysfunction in COVID-19: The Interplay Between Inflammation, Viral Infection and the Coagulation System. Blood Rev (2021) 46:100745. doi: 10.1016/j.blre.2020.100745</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2020.100745</ArticleId><ArticleId IdType="pmc">PMC7444609</ArticleId><ArticleId IdType="pubmed">32868115</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. . Endothelial Dysfunction and Immunothrombosis as Key Pathogenic Mechanisms in COVID-19. Nat Rev Immunol (2021) 21(5):319&#x2013;29. doi: 10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G. Hyperinflammation and Derangement of Renin-Angiotensin-Aldosterone System in COVID-19: A Novel Hypothesis for Clinically Suspected Hypercoagulopathy and Microvascular Immunothrombosis. Clin Chim Acta (2020) 507:167&#x2013;73. doi: 10.1016/j.cca.2020.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7195008</ArticleId><ArticleId IdType="pubmed">32348783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K. Thromboembolic Risk and Anticoagulant Therapy in COVID-19 Patients: Emerging Evidence and Call for Action. Br J Haematol (2020) 189(5):846&#x2013;7. doi:&#xa0;10.1111/bjh.16727</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16727</ArticleId><ArticleId IdType="pmc">PMC7264537</ArticleId><ArticleId IdType="pubmed">32304577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. . Coagulopathy and Antiphospholipid Antibodies in Patients With Covid-19. N Engl J Med (2020) 382(17):e38. doi: 10.1056/NEJMc2007575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2007575</ArticleId><ArticleId IdType="pmc">PMC7161262</ArticleId><ArticleId IdType="pubmed">32268022</ArticleId></ArticleIdList></Reference><Reference><Citation>Farghaly S, Makboul M. Correlation Between Age, Sex, and Severity of Coronavirus Disease-19 Based on Chest Computed Tomography Severity Scoring System. Egypt J Radiol Nucl Med (2021) 52(1):23. doi: 10.1186/s43055-021-00408-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-021-00408-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadi N, Wu SC, Spihlman AP, Moulton VR. What&#x2019;s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses. Front Immunol (2020) 11:2147. doi: 10.3389/fimmu.2020.02147</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.02147</ArticleId><ArticleId IdType="pmc">PMC7485092</ArticleId><ArticleId IdType="pubmed">32983176</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley JH, Conway EM. Cross Talk Pathways Between Coagulation and Inflammation. Circ Res (2016) 118(9):1392&#x2013;408. doi:&#xa0;10.1161/CIRCRESAHA.116.306853</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.306853</ArticleId><ArticleId IdType="pubmed">27126649</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-Related Coagulopathy: A Review of Pathophysiology and Pharmaceutical Management. Cell Biol Int (2021) 45(9):1832&#x2013;50. doi:&#xa0;10.1002/cbin.11623</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.11623</ArticleId><ArticleId IdType="pmc">PMC8239905</ArticleId><ArticleId IdType="pubmed">33945651</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell LM, Johnston CI, Tikellis C, Cooper ME. ACE2, A New Regulator of the Renin-Angiotensin System. Trends Endocrinol Metab (2004) 15(4):166&#x2013;9. doi: 10.1016/j.tem.2004.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2004.03.001</ArticleId><ArticleId IdType="pmc">PMC7128798</ArticleId><ArticleId IdType="pubmed">15109615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. J Pathol (2004) 203(2):631&#x2013;7. doi: 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M, Marzi A, Munster V. Functional Assessment of Cell Entry and Receptor Usage for SARS-CoV-2 and Other Lineage B Betacoronaviruses. Nat Microbiol (2020) 5(4):562&#x2013;9. doi: 10.1038/s41564-020-0688-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural Basis for the Recognition of SARS-CoV-2 by Full-Length Human ACE2. Science (80-) (2020) 367(6485):1444&#x2013;8. doi: 10.1126/science.abb2762</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos RAS, Oudit GY, Verano-Braga T, Canta G, Steckelings UM, Bader M. The Renin-Angiotensin System: Going Beyond the Classical Paradigms. Am J Physiol - Hear Circ Physiol (2019) 316(5):H958&#x2013;70. doi: 10.1152/ajpheart.00723.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00723.2018</ArticleId><ArticleId IdType="pmc">PMC7191626</ArticleId><ArticleId IdType="pubmed">30707614</ArticleId></ArticleIdList></Reference><Reference><Citation>Underwood PC, Adler GK. The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans. Curr Hypertens Rep (2013) 15(1):59&#x2013;70. doi: 10.1007/s11906-012-0323-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-012-0323-2</ArticleId><ArticleId IdType="pmc">PMC3551270</ArticleId><ArticleId IdType="pubmed">23242734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, Jiang C, Penninger JM. Lessons From SARS: Control of Acute Lung Failure by the SARS Receptor ACE2. J Mol Med (2006) 84(10):814&#x2013;20. doi: 10.1007/s00109-006-0094-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-006-0094-9</ArticleId><ArticleId IdType="pmc">PMC7079827</ArticleId><ArticleId IdType="pubmed">16988814</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. . SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med (2020) 382(12):1177&#x2013;9. doi: 10.1056/NEJMc2001737</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2001737</ArticleId><ArticleId IdType="pmc">PMC7121626</ArticleId><ArticleId IdType="pubmed">32074444</ArticleId></ArticleIdList></Reference><Reference><Citation>Han SH, Mallampalli RK. The Role of Surfactant in Lung Disease and Host Defense Against Pulmonary Infections. Ann Am Thorac Soc (2015) 12(5):765&#x2013;74. doi: 10.1513/AnnalsATS.201411-507FR</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201411-507FR</ArticleId><ArticleId IdType="pmc">PMC4418337</ArticleId><ArticleId IdType="pubmed">25742123</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. . Pathological Findings of COVID-19 Associated With Acute Respiratory Distress Syndrome. Lancet Respir Med (2020) 8(4):420&#x2013;2. doi: 10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralinski LE, Baric RS. Molecular Pathology of Emerging Coronavirus Infections. J Pathol (2015) 235(2):185&#x2013;95. doi:&#xa0;10.1002/path.4454</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4454</ArticleId><ArticleId IdType="pmc">PMC4267971</ArticleId><ArticleId IdType="pubmed">25270030</ArticleId></ArticleIdList></Reference><Reference><Citation>Parit R, Jayavel S. Association of ACE Inhibitors and Angiotensin Type II Blockers With ACE2 Overexpression in COVID-19 Comorbidities: A Pathway-Based Analytical Study. Eur J Pharmacol (2021) 896:173899. doi: 10.1016/j.ejphar.2021.173899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.173899</ArticleId><ArticleId IdType="pmc">PMC7839513</ArticleId><ArticleId IdType="pubmed">33508281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. . Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2. Circulation (2005) 111(20):2605&#x2013;10. doi: 10.1161/CIRCULATIONAHA.104.510461</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrosa MA, Valenzuela R, Garrido-Gil P, Labandeira CM, Navarro G, Franco R, et al. . Experimental Data Using Candesartan and Captopril Indicate No Double-Edged Sword Effect in COVID-19. Clin Sci (2021) 135(3):465&#x2013;81. doi: 10.1042/CS20201511</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20201511</ArticleId><ArticleId IdType="pmc">PMC7851407</ArticleId><ArticleId IdType="pubmed">33479758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Gheblawi M, Oudit GY. Angiotensin Converting Enzyme 2: A Double-Edged Sword. Circulation (2020) 142(5):426&#x2013;8. doi: 10.1161/CIRCULATIONAHA.120.047049</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047049</ArticleId><ArticleId IdType="pubmed">32213097</ArticleId></ArticleIdList></Reference><Reference><Citation>Onweni CL, Zhang YS, Caulfield T, Hopkins CE, Fairweather DL, Freeman WD. ACEI/ARB Therapy in COVID-19: The Double-Edged Sword of ACE2 and SARS-CoV-2 Viral Docking. Crit Care (2020) 24(1):475. doi: 10.1186/s13054-020-03195-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03195-9</ArticleId><ArticleId IdType="pmc">PMC7393248</ArticleId><ArticleId IdType="pubmed">32736573</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, et al. . A Mechanistic Model and Therapeutic Interventions for Covid-19 Involving a Ras-Mediated Bradykinin Storm. Elife (2020) 9:1&#x2013;16. doi: 10.7554/eLife.59177</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59177</ArticleId><ArticleId IdType="pmc">PMC7410499</ArticleId><ArticleId IdType="pubmed">32633718</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoneaux R, Shafer SL. A RAS and Bradykinin-Mediated Mechanism for COVID-19. ASA Monit (2020) 84(11):1&#x2013;11. doi: 10.1097/01.ASM.0000722064.35978.f6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASM.0000722064.35978.f6</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Li L, Xu M, Wu J, Luo D, Zhu YS, et al. . Prognostic Value of Interleukin-6, C-Reactive Protein, and Procalcitonin in Patients With COVID-19. J Clin Virol (2020) 127:104370. doi: 10.1016/j.jcv.2020.104370</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104370</ArticleId><ArticleId IdType="pmc">PMC7194648</ArticleId><ArticleId IdType="pubmed">32344321</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations. Clin Infect Dis (2020) 71(15):870&#x2013;4. doi: 10.1093/cid/ciaa329</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa329</ArticleId><ArticleId IdType="pmc">PMC7184340</ArticleId><ArticleId IdType="pubmed">32215613</ArticleId></ArticleIdList></Reference><Reference><Citation>Banu N, Panikar SS, Leal LR, Leal AR. Protective Role of ACE2 and Its Downregulation in SARS-CoV-2 Infection Leading to Macrophage Activation Syndrome: Therapeutic Implications. Life Sci (2020) 256:117905. doi: 10.1016/j.lfs.2020.117905</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117905</ArticleId><ArticleId IdType="pmc">PMC7832382</ArticleId><ArticleId IdType="pubmed">32504757</ArticleId></ArticleIdList></Reference><Reference><Citation>Foresta C, Rocca MS, Di Nisio A. Gender Susceptibility to COVID-19: A Review of the Putative Role of Sex Hormones and X Chromosome. J&#xa0;Endocrinol Invest (2021) 44(5):951&#x2013;6. doi:&#xa0;10.1007/s40618-020-01383-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01383-6</ArticleId><ArticleId IdType="pmc">PMC7492232</ArticleId><ArticleId IdType="pubmed">32936429</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov K, Avidan MS, Benn CS, Bertozzi SM, Blatt L, Chang AY, et al. . Old Vaccines for New Infections: Exploiting Innate Immunity to Control COVID-19 and Prevent Future Pandemics. Proc Natl Acad Sci USA (2021) 118(21):e2101718118. doi: 10.1073/pnas.2101718118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101718118</ArticleId><ArticleId IdType="pmc">PMC8166166</ArticleId><ArticleId IdType="pubmed">34006644</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JS, Warrington R, Watson W, Kim HL. An Introduction to Immunology and Immunopathology. Allergy Asthma Clin Immunol (2018) 14(2):1&#x2013;10. doi:&#xa0;10.1186/s13223-018-0278-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-018-0278-1</ArticleId><ArticleId IdType="pmc">PMC6156898</ArticleId><ArticleId IdType="pubmed">30263032</ArticleId></ArticleIdList></Reference><Reference><Citation>Amarante-Mendes GP, Adjemian S, Branco LM, Zanetti LC, Weinlich R, Bortoluci KR. Pattern Recognition Receptors and the Host Cell Death Molecular Machinery. Front Immunol (2018) 9:2379. doi: 10.3389/fimmu.2018.02379</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02379</ArticleId><ArticleId IdType="pmc">PMC6232773</ArticleId><ArticleId IdType="pubmed">30459758</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh R, Mosser DM. Pattern Recognition Receptors in Innate Immunity, Host Defense, and Immunopathology. Am J Physiol - Adv Physiol Educ (2013) 37(4):284&#x2013;91. doi:&#xa0;10.1152/advan.00058.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/advan.00058.2013</ArticleId><ArticleId IdType="pmc">PMC4089092</ArticleId><ArticleId IdType="pubmed">24292903</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen S, Thomsen AR. Sensing of RNA Viruses: A Review of Innate Immune Receptors Involved in Recognizing RNA Virus Invasion. J Virol (2012) 86(6):2900&#x2013;10. doi: 10.1128/JVI.05738-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05738-11</ArticleId><ArticleId IdType="pmc">PMC3302314</ArticleId><ArticleId IdType="pubmed">22258243</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu KL, Kok KH, Ng MHJ, Poon VKM, Yuen KY, Zheng BJ, et al. . Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding Theformation of TRAF3&#xb7;TANK&#xb7;Tbk1/Ikk&#x3f5; Complex. J Biol Chem (2009) 284(24):16202&#x2013;9. doi: 10.1074/jbc.M109.008227</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.008227</ArticleId><ArticleId IdType="pmc">PMC2713514</ArticleId><ArticleId IdType="pubmed">19380580</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboudounya MM, Heads RJ. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation. Mediators Inflamm (2021) 2021:8874339. doi: 10.1155/2021/8874339</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8874339</ArticleId><ArticleId IdType="pmc">PMC7811571</ArticleId><ArticleId IdType="pubmed">33505220</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SW, Wang CY, Jou YJ, Huang SH, Hsiao LH, Wan L, et al. . SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway Through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6. Int J Mol Sci (2016) 17(5):678. doi: 10.3390/ijms17050678</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17050678</ArticleId><ArticleId IdType="pmc">PMC4881504</ArticleId><ArticleId IdType="pubmed">27164085</ArticleId></ArticleIdList></Reference><Reference><Citation>Taefehshokr N, Taefehshokr S, Hemmat N, Heit B. Covid-19: Perspectives on Innate Immune Evasion. Front Immunol (2020) 11:580641. doi: 10.3389/fimmu.2020.580641</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.580641</ArticleId><ArticleId IdType="pmc">PMC7554241</ArticleId><ArticleId IdType="pubmed">33101306</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoops K, Kikkert M, Van Den Worm SHE, Zevenhoven-Dobbe JC, van der Meer Y, Koster AJ, et al. . SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum. PloS Biol (2008) 6(9):1957&#x2013;74. doi: 10.1371/journal.pbio.0060226</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060226</ArticleId><ArticleId IdType="pmc">PMC2535663</ArticleId><ArticleId IdType="pubmed">18798692</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M&#xf8;ller R, et al. . Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell (2020) 181(5):1036&#x2013;45.e9. doi: 10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. . Impaired Type I Interferon Activity and Inflammatory Responses in Severe COVID-19 Patients. Science (80-) (2020) 369(6504):718&#x2013;24. doi: 10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Wang W. Auto-Antibodies Against Type I IFNs Are Associated With Severe COVID-19 Pneumonia. Signal Transduct Target Ther (2021) 6(1):1&#x2013;2. doi: 10.1038/s41392-021-00514-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00514-6</ArticleId><ArticleId IdType="pmc">PMC7908001</ArticleId><ArticleId IdType="pubmed">33637681</ArticleId></ArticleIdList></Reference><Reference><Citation>Onabajo OO, Banday AR, Stanifer ML, Yan W, Obajemu A, Santer DM, et al. . Interferons and Viruses Induce a Novel Truncated ACE2 Isoform and Not the Full-Length SARS-CoV-2 Receptor. Nat Genet (2020) 52(12):1283&#x2013;93. doi: 10.1038/s41588-020-00731-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00731-9</ArticleId><ArticleId IdType="pmc">PMC9377523</ArticleId><ArticleId IdType="pubmed">33077916</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Sato S, Sotoyama Y, Orba Y, Sawa H, Yamauchi H, et al. . RIG-I Triggers a Signaling-Abortive Anti-SARS-CoV-2 Defense in Human Lung Cells. Nat Immunol (2021) 22(7):820&#x2013;8. doi: 10.1038/s41590-021-00942-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00942-0</ArticleId><ArticleId IdType="pubmed">33976430</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Matthay MA, Calfee CS. Is a &#x201c;Cytokine Storm&#x201d; Relevant to COVID-19? JAMA Intern Med (2020) 180(9):1152&#x2013;4. doi: 10.1001/jamainternmed.2020.3313</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3313</ArticleId><ArticleId IdType="pubmed">32602883</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu KL, Chan CP, Kok KH, Chiu-Yat Woo P, Jin DY. Suppression of Innate Antiviral Response by Severe Acute Respiratory Syndrome Coronavirus M Protein Is Mediated Through the First Transmembrane Domain. Cell Mol Immunol (2014) 11(2):141&#x2013;9. doi: 10.1038/cmi.2013.61</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2013.61</ArticleId><ArticleId IdType="pmc">PMC4003381</ArticleId><ArticleId IdType="pubmed">24509444</ArticleId></ArticleIdList></Reference><Reference><Citation>The REMAP-CAP Investigators. Derde LPG. Effectiveness of Tocilizumab, Sarilumab, and Anakinra for Critically Ill Patients With COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial. medRxiv (2021) 2021.06.18.21259133. doi: 10.1101/2021.06.18.21259133</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.18.21259133</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasaraju T, Tang BM, Herrmann M, Muller S, Chow VTK, Radic M. Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19. Front Pharmacol (2020) 11:870. doi: 10.3389/fphar.2020.00870</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00870</ArticleId><ArticleId IdType="pmc">PMC7291833</ArticleId><ArticleId IdType="pubmed">32581816</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: A Collision of Complement, Coagulation and Inflammatory Pathways. J Thromb Haemost (2020) 18(9):2110&#x2013;7. doi:&#xa0;10.1111/jth.14981</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14981</ArticleId><ArticleId IdType="pmc">PMC7361520</ArticleId><ArticleId IdType="pubmed">32608159</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. . Immunology of COVID-19: Current State of the Science. Immunity (2020) 52(6):910&#x2013;41. doi: 10.1016/j.immuni.2020.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients From Wuhan, China. Intensive Care Med (2020) 46(5):846&#x2013;8. doi: 10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Li T, Han M, Li X, Wu D, Xu Y, et al. . Diagnostic Utility of Clinical Laboratory Data Determinations for Patients With the Severe COVID-19. J&#xa0;Med Virol (2020) 92(7):791&#x2013;6. doi:&#xa0;10.1002/jmv.25770</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25770</ArticleId><ArticleId IdType="pmc">PMC7228247</ArticleId><ArticleId IdType="pubmed">32181911</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. . Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis (2020) 71(15):762&#x2013;8. doi: 10.1093/cid/ciaa248</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. . Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19. Nature (2020) 584(7821):463&#x2013;9. doi: 10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. . Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019. Clin Infect Dis (2020) 71(8):1937&#x2013;42. doi: 10.1093/cid/ciaa449</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa449</ArticleId><ArticleId IdType="pmc">PMC7184354</ArticleId><ArticleId IdType="pubmed">32301997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wu K, Wang D, Yue X, Song D, Zhu Y, et al. . Nucleocapsid Protein of SARS-CoV Activates Interleukin-6 Expression Through Cellular Transcription Factor NF-&#x3ba;b. Virology (2007) 365(2):324&#x2013;35. doi: 10.1016/j.virol.2007.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2007.04.009</ArticleId><ArticleId IdType="pmc">PMC7103332</ArticleId><ArticleId IdType="pubmed">17490702</ArticleId></ArticleIdList></Reference><Reference><Citation>Merza M, Hartman H, Rahman M, Hwaiz R, Zhang E, Renstr&#xf6;m E, et al. . Neutrophil Extracellular Traps Induce Trypsin Activation, Inflammation, and Tissue Damage in Mice With Severe Acute Pancreatitis. Gastroenterology (2015) 149(7):1920&#x2013;31.e8. doi: 10.1053/j.gastro.2015.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2015.08.026</ArticleId><ArticleId IdType="pubmed">26302488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet (2020) 395(10229):1033&#x2013;4. doi: 10.1016/S0140-6736(20)30628-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, et al. . Targeting Potential Drivers of COVID-19: Neutrophil Extracellular Traps. J Exp Med (2020) 217(6):e20200652. doi:&#xa0;10.1084/jem.20200652</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200652</ArticleId><ArticleId IdType="pmc">PMC7161085</ArticleId><ArticleId IdType="pubmed">32302401</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalmurti N, Hunter CA. Cytokine Storms: Understanding COVID-19. Immunity (2020) 53(1):19&#x2013;25. doi: 10.1016/j.immuni.2020.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.017</ArticleId><ArticleId IdType="pmc">PMC7321048</ArticleId><ArticleId IdType="pubmed">32610079</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosseini A, Hashemi V, Shomali N, Asghari F, Gharibi T, Akbari M, et al. . Innate and Adaptive Immune Responses Against Coronavirus. BioMed Pharmacother (2020) 132:110859. doi: 10.1016/j.biopha.2020.110859</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110859</ArticleId><ArticleId IdType="pmc">PMC7580677</ArticleId><ArticleId IdType="pubmed">33120236</ArticleId></ArticleIdList></Reference><Reference><Citation>Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: Pathogenesis, Cytokine Storm and Therapeutic Potential of Interferons. Cytokine Growth Factor Rev (2020) 53:66&#x2013;70. doi: 10.1016/j.cytogfr.2020.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7204669</ArticleId><ArticleId IdType="pubmed">32418715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. ImmunoTargets Ther (2021) 10:63&#x2013;85. doi: 10.2147/ITT.S280706</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ITT.S280706</ArticleId><ArticleId IdType="pmc">PMC7955763</ArticleId><ArticleId IdType="pubmed">33728277</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiaansen A, Varga SM, Spencer JV. Viral Manipulation of the Host Immune Response. Curr Opin Immunol (2015) 36:54&#x2013;60. doi: 10.1016/j.coi.2015.06.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2015.06.012</ArticleId><ArticleId IdType="pmc">PMC4593765</ArticleId><ArticleId IdType="pubmed">26177523</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Zhao J, Perlman S. T Cell-Mediated Immune Response to Respiratory Coronaviruses. Immunol Res (2014) 59(1&#x2013;3):118&#x2013;28. doi: 10.1007/s12026-014-8534-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-014-8534-z</ArticleId><ArticleId IdType="pmc">PMC4125530</ArticleId><ArticleId IdType="pubmed">24845462</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerutti G, Guo Y, Zhou T, Gorman J, Lee M, Rapp M, et al. . Potent SARS-CoV-2 Neutralizing Antibodies Directed Against Spike N-Terminal Domain Target a Single Supersite. Cell Host Microbe (2021) 29(5):819&#x2013;33.e7. doi: 10.1016/j.chom.2021.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC7953435</ArticleId><ArticleId IdType="pubmed">33789084</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools. Virol Sin (2020) 35(3):266&#x2013;71. doi: 10.1007/s12250-020-00207-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00207-4</ArticleId><ArticleId IdType="pmc">PMC7090474</ArticleId><ArticleId IdType="pubmed">32125642</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, et al. . New-Onset IgG Autoantibodies in Hospitalized Patients With COVID-19. Nat Commun (2021) 12(1):1&#x2013;15. doi: 10.1038/s41467-021-25509-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al. . Autoantibodies Neutralizing Type I IFNs Are Present in ~4% of Uninfected Individuals Over 70 Years Old and Account for ~20% of COVID-19 Deaths. Sci Immunol (2021) 6(62):eabl4340. doi: 10.1126/sciimmunol.abl4340</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. . Diverse Functional Autoantibodies in Patients With COVID-19. Nature (2021) 595(7866):283&#x2013;8. doi: 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Taefehshokr N, Taefehshokr S, Heit B. Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2. Pathogens (2020) 9(12):1&#x2013;21. doi: 10.3390/pathogens9121027</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9121027</ArticleId><ArticleId IdType="pmc">PMC7762606</ArticleId><ArticleId IdType="pubmed">33302366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Zhao J, Perlman S. T Cell Responses Are Required for Protection From Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice. J Virol (2010) 84(18):9318&#x2013;25. doi: 10.1128/JVI.01049-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01049-10</ArticleId><ArticleId IdType="pmc">PMC2937604</ArticleId><ArticleId IdType="pubmed">20610717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, John Wherry E. T Cell Responses in Patients With COVID-19. Nat Rev Immunol (2020) 20(9):529&#x2013;36. doi: 10.1038/s41577-020-0402-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0402-6</ArticleId><ArticleId IdType="pmc">PMC7389156</ArticleId><ArticleId IdType="pubmed">32728222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. T-Cell Dysregulation in COVID-19. Biochem Biophys Res Commun (2021) 538:204&#x2013;10. doi: 10.1016/j.bbrc.2020.10.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.10.079</ArticleId><ArticleId IdType="pmc">PMC7648511</ArticleId><ArticleId IdType="pubmed">33220925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, et al. . Comprehensive Mapping of Immune Perturbations Associated With Severe COVID-19. Sci Immunol (2020) 5(49):eabd7114. doi: 10.1126/sciimmunol.abd7114</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd7114</ArticleId><ArticleId IdType="pmc">PMC7402634</ArticleId><ArticleId IdType="pubmed">32669287</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. . Complex Immune Dysregulation in COVID-19 Patients With Severe Respiratory Failure. Cell Host Microbe (2020) 27(6):992&#x2013;1000.e3. doi: 10.1016/j.chom.2020.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. . Impaired Immune Cell Cytotoxicity in Severe COVID-19 Is IL-6 Dependent. J Clin Invest (2020) 130(9):4694&#x2013;703. doi: 10.1172/JCI138554</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138554</ArticleId><ArticleId IdType="pmc">PMC7456250</ArticleId><ArticleId IdType="pubmed">32463803</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. . Single-Cell Landscape of Bronchoalveolar Immune Cells in Patients With COVID-19. Nat Med (2020) 26(6):842&#x2013;4. doi: 10.1038/s41591-020-0901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, L&#xfc;tgehetmann M, Steurer S, Edler C, Heinemann A, et al. . Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med (2020) 173(4):268&#x2013;77. doi:&#xa0;10.7326/M20-2003</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrotri M, van Schalkwyk MCI, Post N, Eddy D, Huntley C, Leeman D, et al. . T Cell Response to SARS-Cov-2 Infection in Humans: A Systematic Review. PloS One (2021) 16(1 January):e0245532. doi:&#xa0;10.1371/journal.pone.0245532</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245532</ArticleId><ArticleId IdType="pmc">PMC7833159</ArticleId><ArticleId IdType="pubmed">33493185</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ttcher JP, Schanz O, Garbers C, Zaremba A, Hegenbarth S, Kurts C, et al. . IL-6 Trans-Signaling-Dependent Rapid Development of Cytotoxic CD8+ T Cell Function. Cell Rep (2014) 8(5):1318&#x2013;27. doi: 10.1016/j.celrep.2014.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.07.008</ArticleId><ArticleId IdType="pubmed">25199826</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga K, Tosato G. IL-10 Inhibits Human T Cell Proliferation and IL-2 Production. J Immunol (Baltimore Md&#xa0;: 1950) (1992) 148:1143&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1737931</ArticleId></ArticleIdList></Reference><Reference><Citation>Waal Malefyt R, Haanen J, Spits H, Koncarolo MG, Te Velde A, Figdor C, et al. . Interleukin 10 (Il-10) and Viral Il-10 Strongly Reduce Antigen-Specific Human T Cell Proliferation by Diminishing the Antigen-Presenting Capacity of Monocytes via Dowm&#x2019;egulation of Class H Major Histocompatibility Complex Expression. J Exp Med (1991) 174(4):915&#x2013;24. doi: 10.1084/jem.174.4.915</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.174.4.915</ArticleId><ArticleId IdType="pmc">PMC2118975</ArticleId><ArticleId IdType="pubmed">1655948</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. . Neutrophil-To-Lymphocyte Ratio as an Independent Risk Factor for Mortality in Hospitalized Patients With COVID-19. J Infect (2020) 81(1):e6&#x2013;12. doi: 10.1016/j.jinf.2020.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7195072</ArticleId><ArticleId IdType="pubmed">32283162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Shi N, Fan Y, Wang J, Zhao C, Li G, et al. . Predictive Value of the Neutrophil-To-Lymphocyte Ratio(NLR) for Diagnosis and Worse Clinical Course of the COVID-19: Findings From Ten Provinces in China. SSRN Electron J (2020). doi: 10.2139/ssrn.3569838</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3569838</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L, et al. . Lymphopenia-Induced T Cell Proliferation Is a Hallmark of Severe COVID-19. bioRxiv (2020) 2020.08.04.236521. doi:&#xa0;10.1101/2020.08.04.236521</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.04.236521</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardhana SA, Wolchok JD. The Many Faces of the Anti-COVID Immune Response. J Exp Med (2020) 217(6):e20200678. doi: 10.1084/jem.20200678</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200678</ArticleId><ArticleId IdType="pmc">PMC7191310</ArticleId><ArticleId IdType="pubmed">32353870</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhang J, Chen Y, Luo B, Yuan Y, Huang F, et al. . The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion Through Potently Downregulating MHC-I. bioRxiv (2020) 2020.05.24.111823. doi:&#xa0;10.1101/2020.05.24.111823v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.24.111823v1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. . Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol (2020) 11:827. doi:&#xa0;10.3389/fimmu.2020.00827</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Dai T, Zhou X, Qian H, Guo R, Lei L, et al. . Analysis of Adaptive Immune Cell Populations and Phenotypes in the Patients Infected by SARS-CoV-2. medRxiv (2020) 2020.03.23.20040675. doi:&#xa0;10.1101/2020.03.23.20040675v2</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.23.20040675v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, et al. . PD-1-Expressing SARS-CoV-2-Specific CD8+ T Cells Are Not Exhausted, But Functional in Patients With COVID-19. Immunity (2021) 54(1):44&#x2013;52.e3. doi: 10.1016/j.immuni.2020.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7834198</ArticleId><ArticleId IdType="pubmed">33338412</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. . Functional Exhaustion of Antiviral Lymphocytes in COVID-19 Patients. Cell Mol Immunol (2020) 17(5):533&#x2013;5. doi: 10.1038/s41423-020-0402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference><Reference><Citation>Oja AE, Saris A, Ghandour CA, Kragten NAM, Hogema BM, Nossent EJ, et al. . Divergent SARS-CoV-2-Specific T and B Cell Responses in Severe But Not Mild COVID-19. bioRxiv (2020) 2020.06.18.159202. doi:&#xa0;10.1101/2020.06.18.159202v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.18.159202v1</ArticleId><ArticleId IdType="pubmed">33073359</ArticleId></ArticleIdList></Reference><Reference><Citation>Bongen E, Lucian H, Khatri A, Fragiadakis GK, Bjornson ZB, Nolan GP, et al. . Sex Differences in the Blood Transcriptome Identify Robust Changes in Immune Cell Proportions With Aging and Influenza Infection. Cell Rep (2019) 29(7):1961&#x2013;73.e4. doi: 10.1016/j.celrep.2019.10.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.10.019</ArticleId><ArticleId IdType="pmc">PMC6856718</ArticleId><ArticleId IdType="pubmed">31722210</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. . Sex Differences in Immune Responses That Underlie COVID-19 Disease Outcomes. Nature (2020) 588(7837):315&#x2013;20. doi: 10.1038/s41586-020-2700-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Viveiros A, Rasmuson J, Vu J, Mulvagh SL, Yip CYY, Norris CM, et al. . Sex Differences in COVID-19: Candidate Pathways, Genetics of ACE2, and Sex Hormones. Am J Physiol - Hear Circ Physiol (2021) 320(1):H296&#x2013;304. doi:&#xa0;10.1152/ajpheart.00755.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00755.2020</ArticleId><ArticleId IdType="pmc">PMC8083171</ArticleId><ArticleId IdType="pubmed">33275517</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinna G. Sex and COVID-19: A Protective Role for Reproductive Steroids. Trends Endocrinol Metab (2021) 32(1):3&#x2013;6. doi: 10.1016/j.tem.2020.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7649655</ArticleId><ArticleId IdType="pubmed">33229187</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, et al. . Androgen Receptor: An Overview. Crit Rev Eukaryot Gene Expr (1995) 5(2):97&#x2013;125. doi: 10.1615/CritRevEukarGeneExpr.v5.i2.10</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevEukarGeneExpr.v5.i2.10</ArticleId><ArticleId IdType="pubmed">8845584</ArticleId></ArticleIdList></Reference><Reference><Citation>Younis JS, Skorecki K, Abassi Z. The Double Edge Sword of Testosterone&#x2019;s Role in the COVID-19 Pandemic. Front Endocrinol (Lausanne) (2021) 12:607179. doi: 10.3389/fendo.2021.607179</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.607179</ArticleId><ArticleId IdType="pmc">PMC8009245</ArticleId><ArticleId IdType="pubmed">33796068</ArticleId></ArticleIdList></Reference><Reference><Citation>Abobaker A, Raba AA. Does COVID-19 Affect Male Fertility? World J Urol (2021) 39(3):975&#x2013;6. doi: 10.1007/s00345-020-03208-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-020-03208-w</ArticleId><ArticleId IdType="pmc">PMC7171435</ArticleId><ArticleId IdType="pubmed">32318855</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder M, Schaumburg B, Mueller Z, Parplys A, Jarczak D, Nierhaus A, et al. . The Majority of Male Patients With COVID-19 Present Low Testosterone Levels on Admission to Intensive Care in Hamburg, Germany: A Retrospective Cohort Study. medRxiv (2020) 2020.05.07.20073817.</Citation></Reference><Reference><Citation>Wang J, Saguner AM, An J, Ning Y, Yan Y, Li G. Dysfunctional Coagulation in COVID-19: From Cell to Bedside. Adv Ther (2020) 37(7):3033&#x2013;9. doi: 10.1007/s12325-020-01399-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-020-01399-7</ArticleId><ArticleId IdType="pmc">PMC7274265</ArticleId><ArticleId IdType="pubmed">32504450</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, et al. . Hematological Findings and Complications of COVID-19. Am J Hematol (2020) 95(7):834&#x2013;47. doi: 10.1002/ajh.25829</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, van der Poll T. Inflammation and Coagulation. Crit Care Med (2010) 38(SUPPL 2):S26&#x2013;34. doi: 10.1097/CCM.0b013e3181c98d21</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181c98d21</ArticleId><ArticleId IdType="pubmed">20083910</ArticleId></ArticleIdList></Reference><Reference><Citation>Smargiassi A, Soldati G, Borghetti A, Scoppettuolo G, Tamburrini E, Testa AC, et al. . Lung Ultrasonography for Early Management of Patients With Respiratory Symptoms During COVID-19 Pandemic. J Ultrasound (2020) 23(4):449&#x2013;56. doi: 10.1007/s40477-020-00501-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40477-020-00501-7</ArticleId><ArticleId IdType="pmc">PMC7338342</ArticleId><ArticleId IdType="pubmed">32638333</ArticleId></ArticleIdList></Reference><Reference><Citation>Palta S, Saroa R, Palta A. Overview of the Coagulation System. Indian J Anaesth (2014) 58(5):515&#x2013;23. doi: 10.4103/0019-5049.144643</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5049.144643</ArticleId><ArticleId IdType="pmc">PMC4260295</ArticleId><ArticleId IdType="pubmed">25535411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezihe-Ejiofor JA, Hutchinson N. Anticlotting Mechanisms 1: Physiology and Pathology. Contin Educ Anaesth Crit Care Pain (2013) 13(3):87&#x2013;92. doi: 10.1093/bjaceaccp/mks061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bjaceaccp/mks061</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J, Spittle DA, Newnham M. COVID-19, Immunothrombosis and Venous Thromboembolism: Biological Mechanisms. Thorax (2021) 76(4):412&#x2013;20. doi: 10.1136/thoraxjnl-2020-216243</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216243</ArticleId><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorini FL, Di Matteo M, Gritti P, Grazioli L, Benigni A, Zacchetti L, et al. . Coagulopathy and COVID-19. Eur Hear J Suppl (2021) 23(Supplement_E):E95&#x2013;8. doi: 10.1093/eurheartj/suab100</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab100</ArticleId><ArticleId IdType="pmc">PMC8503535</ArticleId><ArticleId IdType="pubmed">34650364</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantzeskaki F, Armaganidis A, Orfanos SE. Immunothrombosis in Acute Respiratory Distress Syndrome: Cross Talks Between Inflammation and Coagulation. Respiration (2017) 93(3):212&#x2013;25. doi: 10.1159/000453002</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453002</ArticleId><ArticleId IdType="pubmed">27997925</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann B, Massberg S. Thrombosis as an Intravascular Effector of Innate Immunity. Nat Rev Immunol (2013) 13(1):34&#x2013;45. doi: 10.1038/nri3345</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3345</ArticleId><ArticleId IdType="pubmed">23222502</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz C, Engelmann B, Massberg S. Crossroads of Coagulation and Innate Immunity: The Case of Deep Vein Thrombosis. J Thromb Haemost (2013) 11(SUPPL.1):233&#x2013;41. doi:&#xa0;10.1111/jth.12261</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12261</ArticleId><ArticleId IdType="pubmed">23809127</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton K, Dixit VM. Signaling in Innate Immunity and Inflammation. Cold&#xa0;Spring Harb Perspect Biol (2012) 4(3):a006049. doi: 10.1101/cshperspect.a006049</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006049</ArticleId><ArticleId IdType="pmc">PMC3282411</ArticleId><ArticleId IdType="pubmed">22296764</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, Massberg S. Interplay Between Inflammation and Thrombosis in Cardiovascular Pathology. Nat Rev Cardiol (2021) 18(9):666&#x2013;82. doi: 10.1038/s41569-021-00552-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00552-1</ArticleId><ArticleId IdType="pmc">PMC8100938</ArticleId><ArticleId IdType="pubmed">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayarangaiah A, Kariyanna PT, Chen X, Jayarangaiah A, Kumar A. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response. Clin Appl Thromb (2020) 26:1076029620943293. doi:&#xa0;10.1177/1076029620943293</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029620943293</ArticleId><ArticleId IdType="pmc">PMC7401047</ArticleId><ArticleId IdType="pubmed">32735131</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Sharif K, O&#x2019;Regan A, Bridgewood C. The Role of Cytokines Including Interleukin-6 in COVID-19 Induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev (2020) 19(6):102537. doi: 10.1016/j.autrev.2020.102537</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102537</ArticleId><ArticleId IdType="pmc">PMC7195002</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnaubelt S, Tihanyi D, Strassl R, Schmidt R, Anders S, Laggner AN, et al. . Hemophagocytic Lymphohistiocytosis in COVID-19: Case Reports of a Stepwise Approach. Med (Baltimore) (2021) 100(12):e25170. doi: 10.1097/MD.0000000000025170</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000025170</ArticleId><ArticleId IdType="pmc">PMC9281988</ArticleId><ArticleId IdType="pubmed">33761694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz G, Moog P, Bachmann Q, La Ros&#xe9;e P, Schneider H, Schlegl M, et al. . Title: Cytokine Release Syndrome Is Not Usually Caused by Secondary Hemophagocytic Lymphohistiocytosis in a Cohort of 19 Critically Ill COVID-19 Patients. Sci Rep (2020) 10(1):1&#x2013;11. doi: 10.1038/s41598-020-75260-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75260-w</ArticleId><ArticleId IdType="pmc">PMC7589537</ArticleId><ArticleId IdType="pubmed">33106497</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, et al. . Characteristics of Lymphocyte Subsets and Cytokines in Peripheral Blood of 123 Hospitalized Patients With 2019 Novel Coronavirus Pneumonia (NCP). medRxiv (2020) 2020.02.10.20021832. doi:&#xa0;10.1101/2020.02.10.20021832v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.10.20021832v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bamgboje A, Hong J, Mushiyev S, Pekler G. A 61-Year-Old Man With Sars-Cov-2 Infection and Venous Thrombosis Presenting With Painful Swelling and Gangrene of the Lower Limb Consistent With Phlegmasia Cerulea Dolens. Am J Case Rep (2020) 21:1&#x2013;6. doi: 10.12659/AJCR.928342</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.928342</ArticleId><ArticleId IdType="pmc">PMC7750909</ArticleId><ArticleId IdType="pubmed">33323917</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JS, Pasieka HB, Petronic-Rosic V, Sharif-Askary B, Evans KK. Digital Gangrene as a Sign of Catastrophic Coronavirus Disease 2019-Related Microangiopathy. Plast Reconstr Surg - Glob Open (2020) 8(7):e3025. doi: 10.1097/GOX.0000000000003025</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GOX.0000000000003025</ArticleId><ArticleId IdType="pmc">PMC7413788</ArticleId><ArticleId IdType="pubmed">32802690</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. . D-Dimer Levels on Admission to Predict in-Hospital Mortality in Patients With Covid-19. J&#xa0;Thromb Haemost (2020) 18(6):1324&#x2013;9. doi: 10.1111/jth.14859</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14859</ArticleId><ArticleId IdType="pmc">PMC7264730</ArticleId><ArticleId IdType="pubmed">32306492</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D, Ziogas IA, Gianni P. Coagulation Disorders in Coronavirus Infected Patients: COVID-19, SARS-CoV-1, MERS-CoV and Lessons From the Past. J Clin Virol (2020) 127:104362. doi: 10.1016/j.jcv.2020.104362</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104362</ArticleId><ArticleId IdType="pmc">PMC7195278</ArticleId><ArticleId IdType="pubmed">32305883</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Levi M, Levy JH. Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. Semin Thromb Hemost (2020) 46(1):89&#x2013;95. doi: 10.1055/s-0039-1694995</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1694995</ArticleId><ArticleId IdType="pubmed">31443111</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons J, Pittet JF. The Coagulopathy of Acute Sepsis. Curr Opin Anaesthesiol (2015) 28(2):227&#x2013;36. doi: 10.1097/ACO.0000000000000163</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000163</ArticleId><ArticleId IdType="pmc">PMC4407200</ArticleId><ArticleId IdType="pubmed">25590467</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Levy J, Raj A, Warkentin T. Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation. J Clin Med (2019) 8(5):728. doi: 10.3390/jcm8050728</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8050728</ArticleId><ArticleId IdType="pmc">PMC6572234</ArticleId><ArticleId IdType="pubmed">31121897</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Poll T, Van De Veerdonk FL, Scicluna BP, Netea MG. The Immunopathology of Sepsis and Potential Therapeutic Targets. Nat Rev Immunol (2017) 17(7):407&#x2013;20. doi: 10.1038/nri.2017.36</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.36</ArticleId><ArticleId IdType="pubmed">28436424</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological Inflammation in Patients With COVID-19: A Key Role for Monocytes and Macrophages. Nat Rev Immunol (2020) 20(6):355&#x2013;62. doi: 10.1038/s41577-020-0331-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T, Kubli SP, Yoshinaga SK, Pfeffer K, Mak TW. An Aberrant STAT Pathway Is Central to COVID-19. Cell Death Differ (2020) 27(12):3209&#x2013;25. doi: 10.1038/s41418-020-00633-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00633-7</ArticleId><ArticleId IdType="pmc">PMC7545020</ArticleId><ArticleId IdType="pubmed">33037393</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A, Nemati M, Jafarzadeh S. Contribution of STAT3 to the Pathogenesis of COVID-19. Microb Pathog (2021) 154:104836. doi: 10.1016/j.micpath.2021.104836</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.104836</ArticleId><ArticleId IdType="pmc">PMC7937040</ArticleId><ArticleId IdType="pubmed">33691172</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Warnock M, Harbaugh A, Yalavarthi S, Gockman K, Zuo M, et al. .&#xa0;Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Hospitalized COVID-19 Patients. Sci Rep (2021) 11(1):2020.08.29.20184358. doi:&#xa0;10.1101/2020.08.29.20184358v4</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.29.20184358v4</ArticleId><ArticleId IdType="pmc">PMC7810990</ArticleId><ArticleId IdType="pubmed">33452298</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimmino G, Cirillo P. Tissue Factor: Newer Concepts in Thrombosis and Its Role Beyond Thrombosis and Hemostasis. Cardiovasc Diagn Ther (2018) 8(5):581&#x2013;93. doi: 10.21037/cdt.2018.10.14</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt.2018.10.14</ArticleId><ArticleId IdType="pmc">PMC6232348</ArticleId><ArticleId IdType="pubmed">30498683</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. . Neutrophil Extracellular Traps Kill Bacteria. Science (80-) (2004) 303(5663):1532&#x2013;5. doi: 10.1126/science.1092385</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1092385</ArticleId><ArticleId IdType="pubmed">15001782</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, et al. . Vascular Occlusion by Neutrophil Extracellular Traps in COVID-19. EBioMedicine (2020) 58:102925. doi: 10.1016/j.ebiom.2020.102925</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102925</ArticleId><ArticleId IdType="pmc">PMC7397705</ArticleId><ArticleId IdType="pubmed">32745993</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-P&#xe9;rez MP, &#xc1;guila S, Reguil&#xf3;n-Gallego L, los Reyes-Garc&#xed;a AM, Mi&#xf1;ano A, Bravo-P&#xe9;rez C, et al. . Neutrophil Extracellular Traps and Von Willebrand Factor Are Allies That Negatively Influence COVID-19 Outcomes. Clin Transl Med (2021) 11(1):e268. doi:&#xa0;10.1002/ctm2.268</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.268</ArticleId><ArticleId IdType="pmc">PMC7775985</ArticleId><ArticleId IdType="pubmed">33463053</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. . Endotheliopathy in COVID-19-Associated Coagulopathy: Evidence From a Single-Centre, Cross-Sectional Study. Lancet Haematol (2020) 7(8):e575&#x2013;82. doi: 10.1016/S2352-3026(20)30216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. . Neutrophil Extracellular Traps Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome. Blood (2020) 136(10):1169&#x2013;79. doi: 10.1182/blood.2020007008</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007008</ArticleId><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Wu Z, Long Q, Huang J, Hong T, Liu W, et al. . Insights Into Immunothrombosis: The Interplay Among Neutrophil Extracellular Trap, Von Willebrand Factor, and ADAMTS13. Front Immunol (2020) 11:610696. doi: 10.3389/fimmu.2020.610696</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.610696</ArticleId><ArticleId IdType="pmc">PMC7738460</ArticleId><ArticleId IdType="pubmed">33343584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. . Neutrophil Extracellular Traps in COVID-19. JCI Insight (2020) 5(11):e138999. doi:&#xa0;10.1172/jci.insight.138999</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.138999</ArticleId><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, N&#xfa;&#xf1;ez-&#xc1;lvarez C, et al. . Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome. Arthritis Rheumatol (2015) 67(11):2990&#x2013;3003. doi: 10.1002/art.39247</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39247</ArticleId><ArticleId IdType="pmc">PMC4626310</ArticleId><ArticleId IdType="pubmed">26097119</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza-Pinto C, Garc&#xed;a-Carrasco M, Cervera R. Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant). Curr Rheumatol Rep (2018) 20(10):62. doi: 10.1007/s11926-018-0773-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-018-0773-x</ArticleId><ArticleId IdType="pubmed">30123926</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, et al. . Prothrombotic Autoantibodies in Serum From Patients Hospitalized With&#xa0;COVID-19. Sci Transl Med (2020) 12(570):3876. doi: 10.1126/scitranslmed.abd3876</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd3876</ArticleId><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Chousterman BG, Swirski FK, Weber GF. Cytokine Storm and Sepsis Disease Pathogenesis. Semin Immunopathol (2017) 39(5):517&#x2013;28. doi: 10.1007/s00281-017-0639-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0639-8</ArticleId><ArticleId IdType="pubmed">28555385</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;sm&#xfc;ller H, Traxler S, Bitzer M, H&#xe4;berle H, Raiser W, Nann D, et al. . The Evolution of Pulmonary Pathology in Fatal COVID-19 Disease: An Autopsy Study With Clinical Correlation. Virchows Arch (2020) 477(3):349&#x2013;57. doi: 10.1007/s00428-020-02881-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-020-02881-x</ArticleId><ArticleId IdType="pmc">PMC7324489</ArticleId><ArticleId IdType="pubmed">32607684</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;f A, M&#xfc;ller JP, Brehm MA. A Biophysical View on Von Willebrand Factor Activation. J Cell Physiol (2018) 233(2):799&#x2013;810. doi: 10.1002/jcp.25887</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25887</ArticleId><ArticleId IdType="pubmed">28256724</ArticleId></ArticleIdList></Reference><Reference><Citation>South K, Lane DA. ADAMTS-13 and Von Willebrand Factor: A Dynamic Duo. J Thromb Haemost (2018) 16(1):6&#x2013;18. doi: 10.1111/jth.13898</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.13898</ArticleId><ArticleId IdType="pmc">PMC5814862</ArticleId><ArticleId IdType="pubmed">29108103</ArticleId></ArticleIdList></Reference><Reference><Citation>Francischetti IMB, Toomer K, Zhang Y, Jani J, Siddiqui Z, Brotman DJ, et al. . Upregulation of Pulmonary Tissue Factor, Loss of Thrombomodulin and Immunothrombosis in SARS-CoV-2 Infection. EClinicalMedicine (2021) 39:101069. doi: 10.1016/j.eclinm.2021.101069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101069</ArticleId><ArticleId IdType="pmc">PMC8342934</ArticleId><ArticleId IdType="pubmed">34377969</ArticleId></ArticleIdList></Reference><Reference><Citation>Masias C, Cataland SR. The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and Thrombosis. Blood (2018) 132(9):903&#x2013;10. doi: 10.1182/blood-2018-02-791533</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-02-791533</ArticleId><ArticleId IdType="pubmed">30006329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC. Disseminated Intravascular Coagulation: New Identity as Endotheliopathy-Associated Vascular Microthrombotic Disease Based on In Vivo Hemostasis and Endothelial Molecular Pathogenesis. Thromb J (2020) 18(1):1&#x2013;21. doi:&#xa0;10.1186/s12959-020-00231-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-020-00231-0</ArticleId><ArticleId IdType="pmc">PMC7553785</ArticleId><ArticleId IdType="pubmed">33061857</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkrouzman E, Barbhaiya M, Erkan D, Lockshin MD. Reality Check on Antiphospholipid Antibodies in COVID-19&#x2013;Associated Coagulopathy. Arthritis Rheumatol (2021) 73(1):173&#x2013;4. doi:&#xa0;10.1002/art.41472</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41472</ArticleId><ArticleId IdType="pubmed">32901454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ros&#xe1;rio C, Zandman-Goddard G, Meyron-Holtz EG, D&#x2019;Cruz DP, Shoenfeld Y. The Hyperferritinemic Syndrome: Macrophage Activation Syndrome, Still&#x2019;s Disease, Septic Shock and Catastrophic Antiphospholipid Syndrome. BMC Med (2013) 11(1):185. doi: 10.1186/1741-7015-11-185</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-185</ArticleId><ArticleId IdType="pmc">PMC3751883</ArticleId><ArticleId IdType="pubmed">23968282</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. . On the Alert for Cytokine Storm: Immunopathology in COVID-19. Arthritis Rheumatol (2020) 72(7):1059&#x2013;63. doi: 10.1002/art.41285</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41285</ArticleId><ArticleId IdType="pmc">PMC7262347</ArticleId><ArticleId IdType="pubmed">32293098</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. . Complement Associated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19 Infection: A Report of Five Cases. Transl Res (2020) 220:1&#x2013;13. doi: 10.1016/j.trsl.2020.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7158248</ArticleId><ArticleId IdType="pubmed">32299776</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors JM, Levy JH. COVID-19 and Its Implications for Thrombosis and Anticoagulation. Blood (2020) 135(23):2033&#x2013;40. doi: 10.1182/blood.2020006000</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlberg J, Chong DSY, Lai WYY. Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome Than Women Do? Am J Epidemiol (2004) 159(3):229&#x2013;31. doi: 10.1093/aje/kwh056</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh056</ArticleId><ArticleId IdType="pmc">PMC7110237</ArticleId><ArticleId IdType="pubmed">14742282</ArticleId></ArticleIdList></Reference><Reference><Citation>
Leong: SARS in Singapore-Predictors of Disease Severity - Google Scholar. Available&#xa0;at: https://scholar.google.com/scholar_lookup?title=SARSinSingapore&#x2014;predictorsofdiseaseseverity&amp;author=HNLeong&amp;author=AEarnest&amp;author=HHLim&amp;publication_year=2006&amp;journal=AnnAcadMedSingapore&amp;volume=35&amp;pages=326-31.</Citation><ArticleIdList><ArticleId IdType="pubmed">16829999</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. The Pattern of Middle East Respiratory Syndrome Coronavirus in Saudi Arabia: A Descriptive Epidemiological Analysis of Data From the Saudi Ministry of Health. Int J Gen Med (2014) 7:417&#x2013;23. doi: 10.2147/IJGM.S67061</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S67061</ArticleId><ArticleId IdType="pmc">PMC4149400</ArticleId><ArticleId IdType="pubmed">25187734</ArticleId></ArticleIdList></Reference><Reference><Citation>Roach REJ, Cannegieter SC, Lijfering WM. Differential Risks in Men and Women for First and Recurrent Venous Thrombosis: The Role of Genes and Environment. J Thromb Haemost (2014) 12(10):1593&#x2013;600. doi: 10.1111/jth.12678</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12678</ArticleId><ArticleId IdType="pubmed">25081183</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivonello R, Auriemma RS, Pivonello C, Isidori AM, Corona G, Colao A, et al. . Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger? Neuroendocrinology (2021) 111(11):1066&#x2013;85. doi: 10.1159/000513346</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513346</ArticleId><ArticleId IdType="pmc">PMC7900484</ArticleId><ArticleId IdType="pubmed">33242856</ArticleId></ArticleIdList></Reference><Reference><Citation>Erem C, Kocak M, Hacihasanoglu A, Yilmaz M. Blood Coagulation and Fibrinolysis in Male Patient With Hypogonadotropic Hypogonadism: Plasma Factor V and Factor X Activities Increase in Hypogonadotropic Hypogonadism. J&#xa0;Endocrinol Invest (2008) 31(6):537&#x2013;41. doi: 10.1007/BF03346404</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03346404</ArticleId><ArticleId IdType="pubmed">18591887</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy-O&#x2019;Reilly M, McCullough LD. Sex Differences in Stroke: The Contribution of Coagulation. Exp Neurol (2014) 259:16&#x2013;27. doi: 10.1016/j.expneurol.2014.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.02.011</ArticleId><ArticleId IdType="pmc">PMC4127336</ArticleId><ArticleId IdType="pubmed">24560819</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe6;ss IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstr&#xf8;m J. Incidence and Mortality of Venous Thrombosis: A Population-Based Study. J Thromb Haemost (2007) 5(4):692&#x2013;9. doi: 10.1111/j.1538-7836.2007.02450.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02450.x</ArticleId><ArticleId IdType="pubmed">17367492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The Risk of Recurrent Venous Thromboembolism in Men and Women. N&#xa0;Engl J Med (2004) 350(25):2558&#x2013;63. doi:&#xa0;10.1056/NEJMoa032959</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa032959</ArticleId><ArticleId IdType="pubmed">15201412</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzano A, Demelo-Rodriguez P, Marra AM, Proietti M. A Focused Review of Gender Differences in Antithrombotic Therapy. Curr Med Chem (2017) 24(24):2576&#x2013;88. doi: 10.2174/0929867323666161029223512</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867323666161029223512</ArticleId><ArticleId IdType="pubmed">27804874</ArticleId></ArticleIdList></Reference><Reference><Citation>Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk Factors for Venous and Arterial Thrombosis. Blood Transfus (2011) 9(2):120&#x2013;38. doi: 10.2450/2010.0066-10</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2010.0066-10</ArticleId><ArticleId IdType="pmc">PMC3096855</ArticleId><ArticleId IdType="pubmed">21084000</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastrelli G, Di Stasi V, Inglese F, Beccaria M, Garuti M, Di Costanzo D, et al. . Low Testosterone Levels Predict Clinical Adverse Outcomes in SARS-CoV-2 Pneumonia Patients. Andrology (2021) 9(1):88&#x2013;98. doi:&#xa0;10.1111/andr.12821</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12821</ArticleId><ArticleId IdType="pmc">PMC7280645</ArticleId><ArticleId IdType="pubmed">32436355</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Xu X. scRNA-Seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells. Cells (2020) 9(4):3474. doi: 10.3390/cells9040920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040920</ArticleId><ArticleId IdType="pmc">PMC7226809</ArticleId><ArticleId IdType="pubmed">32283711</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females be Protective Against SARS-COV-2 Compared to the Single X-Chromosome in Males? Int J Mol Sci (2020) 21(10):3474. doi: 10.3390/ijms21103474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103474</ArticleId><ArticleId IdType="pmc">PMC7278991</ArticleId><ArticleId IdType="pubmed">32423094</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzoran I, Hoffman R, Monreal M. Hemostasis and Thrombosis in the Oldest Old. Semin Thromb Hemost (2018) 44(7):624&#x2013;31. doi:&#xa0;10.1055/s-0038-1657779</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1657779</ArticleId><ArticleId IdType="pubmed">29920621</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Sci Rep (2021) 11(1):1&#x2013;12. doi: 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. . Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome. J Thromb Haemost (2021) 19(10):2546&#x2013;53. doi:&#xa0;10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>